What is Synopsys's cash, cash equivalents, and marketable securities?

Synopsys (SNPS) reported cash, cash equivalents, and marketable securities of $71.97M in Q1 2026.

Cash, Cash Equivalents, and Marketable Securities

Synopsys Cash, Cash Equivalents, and Marketable Securities decreased by 1.3% to $71.97M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

CategoryLiquidity

SignalHigher is better

VolatilityModerate

First reportedQ4 2025

Last reportedQ2 2026May 27, 2026

How to read this metric

Higher levels provide a larger buffer for operational needs and strategic opportunities, while lower levels may indicate tight liquidity or aggressive capital deployment.

Detailed definition

This is the aggregate of all highly liquid assets, including cash, bank deposits, and short-term marketable securities t...

Peer comparison

A fundamental liquidity metric used by all public companies to assess financial health.

Metric ID: cash_equivalents_marketable_securities_total

Historical Data

2 periods

	Q4 '25	Q2 '26
Value	$72.93M	$71.97M
QoQ Change	—	-1.3%

Range$71.97M – $72.93M

Cash, Cash Equivalents, and Marketable Securities at Other Companies

RambusRMBS View metric

KLA CorporationKLAC View metric

Applied MaterialsAMAT View metric

SemtechSMTC View metric

Frequently Asked Questions

What is Synopsys's cash, cash equivalents, and marketable securities?: Synopsys (SNPS) reported cash, cash equivalents, and marketable securities of $71.97M in Q1 2026.
What does cash, cash equivalents, and marketable securities mean?: The total amount of cash and easily sellable investments the company holds.